Dr. Dinesh  Kumar Badyal
My Social Links

Dr. Dinesh Kumar Badyal

Professor and HOD
Christian Medical College, India


Highest Degree
M.D. in Pharmacology from Postgraduate Institute of Medical Education and Research, India

Share this Profile



Advertisement
Event

Biography

Dr. Dinesh Kumar Badyal holds a position of Professor and Head of the Department of Pharmacology at Christian Medical College, India. He has obtained his M.D. in Pharmacology from Postgraduate Institute of Medical Education and Research, India. His main area of interest focuses on Pharmacology and Toxicology. His main area of expertise includes Efficacy, Safety, Adverse Drug Reaction, Medical Education, and Pharmacokinetics. He has published 4 books and 46 research articles in national and international journals contributed as author/co-author.

Area of Interest:

Pharmacology and Toxicology
100%
Adverse Drug Reaction
62%
Safety
90%
Pharmacokinetics
75%
Efficacy
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Jacob, J.N. and D.K. Badyal, 2014. Biological studies of turmeric oil, Part 3: Anti-inflammatory and analgesic properties of turmeric oil and fish oil in comparison with aspirin. Natural Product Commun., 9: 225-228.
    Direct Link  |  
  2. Badyal, D.K.,2014 2014. Animal use in education in India: Confusion continues. Alternat. Lab. Anim., 42: P63-P64.
  3. Badyal, D.K., C. Desai, S.K. Tripathi, S.P. Dhaneria, S.J. Chandy and B.K. Bezbaruah, 2014. Postgraduate pharmacology curriculum in medical institutions in India: Time for need-based appraisal and modifications. Indian J. Pharmacol., 46: 584-589.
    Direct Link  |  
  4. Badyal, D.K. and C. Desai, 2014. Animal use in education and research: The changing scenario. Indian J. Pharmacol., 46: 257-265.
  5. Kwatra, G., P. Kaur, G. Toor, D.K. Badyal, R. Kaur, Y. Singh and J.D. Pandian, 2013. Cost of stroke from a tertiary center in Northwest India. Neurol. India, 61: 627-632.
    Direct Link  |  
  6. Jacob, J.N., D.K. Badyal, S. Bala and M. Toloue, 2013. Evaluation of the in vivo anti-inflammatory and analgesic and in vitro anti-cancer activities of curcumin and its derivatives. Natural Prod. Commun., 8: 359-362.
    Direct Link  |  
  7. Jacob, J.N., D.K. Badyal and S. Bala, 2013. Evaluation of the in vivo anti‐inflammatory and analgesic activity of a highly water‐soluble aspirin conjugate. Basic Clin. Pharmacol. Toxicol., 112: 171-174.
    CrossRef  |  Direct Link  |  
  8. Badyal, D.K., 2013. Statins: New safety concerns. J. Rational Pharmacother. Res., 1: 81-84.
  9. Matreja, P.S., D.K. Badyal, R.S. Deswal and A. Sharma, 2012. Efficacy and safety of add on low-dose mirtazapine in depression. Indian J. Pharmacol., 44: 173-177.
    Direct Link  |  
  10. Gupta, A.K., D.K. Badyal, P.S. Matreja, P.P. Khosla and M. John, 2012. Efficacy of low dose sibutramine in obese type-2 diabetes mellitus (TDM) Indian patients. Middle East J. Family Med., 10: 29-35.
  11. Gulrez, G., D.K. Badyal, R.S. Deswal and A. Sharma, 2012. Bupropion as an augmenting agent in patients of depression with partial response. Basic Clin. Pharmacol. Toxicol., 110: 227-230.
    CrossRef  |  Direct Link  |  
  12. Chopra, S., D.K. Badyal, P.C. Baby and D. Cherian, 2012. Pulmonary arterial hypertension: Advances in pathophysiology and management. Indian J. Pharmacol., 44: 4-11.
    Direct Link  |  
  13. Suman, B. and D.K. Badyal, 2010. Management of episodic tension type headache. Clin. Res., 3: 79-83.
  14. Gaurav, G. and D.K. Badyal, 2010. Augmentation strategies in depression. Clin. Res., 2: 45-49.
  15. Badyal, D.K., S. Bala and P. Kathuria, 2010. Student evaluation of teaching and assessment methods in pharmacology. Indian J. Pharmacol., 42: 87-89.
    Direct Link  |  
  16. Badyal, D.K., 2010. Depression therapy: Innovations. Clin. Res., 3: 100-102.
  17. Singh, J. and D.K. Badyal, 2009. Prescribing practices in neurology out-patient department in a tertiary care teaching hospital of Northern India. Clin. Res., 2: 15-21.
  18. Modgil, V., D.K. Badyal and A. Verghese, 2009. Rare case of fluticasone allergy: A case report. Clin. Res., 2: 75-77.
  19. Modgil, V., D.K. Badyal and A. Verghese, 2009. Efficacy and safety of montelukast add-on therapy in allergic rhinitis. Meth. Find. Exp. Clin. Pharmacol., 32: 669-674.
    Direct Link  |  
  20. Badyal, D.K., V. Modgill and J. Kaur, 2009. Computer simulation models are implementable as replacements for animal experiments. Alternat. Lab. Anim., 37: 191-195.
    Direct Link  |  
  21. Badyal, D.K., 2009. Impotency: Journey from injectable to oral therapy. Clin. Res., 1: 8-14.
  22. Kaur, J. and D.K. Badyal, 2008. Newer insulins. JK Sci., 10: 107-111.
    Direct Link  |  
  23. Gupta, A., D.K. Badyal, P.P. Khosla, B. Uppal, T.M. Jaison and S. Chopra, 2008. Effect of atorvastatin on hs-CRP in acute coronary syndrome. Br. J. Clin. Pharmacol., 66: 411-413.
    CrossRef  |  Direct Link  |  
  24. George, P., J. Das, B. Pawar and D.K. Badyal, 2008. Gatifloxacin-induced rhabdomyolysis. J. Postgraduate Med., 54: 233-234.
    Direct Link  |  
  25. Badyal, D.K. and J.K. Sitagliptin, 2008. A new class of oral drug for type 2 diabetes. JK Sci., 10: 97-98.
    Direct Link  |  
  26. Matreja, P.S., D.K. Badyal, P. Khosla and R.S. Deswal, 2007. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: Pragmatic randomized open-label comparison. Psychopharmacol. Clin. Exp., 22: 477-482.
    CrossRef  |  Direct Link  |  
  27. Kaur, J., D.K. Badyal and P.P. Khosla, 2007. Monoclonal antibodies: Pharmacological relevance. Indian J. Pharmacol., 39: 5-14.
    Direct Link  |  
  28. Chatley, P., D.K. Badyal, R. Calton and P.P. Khosla, 2007. Combination therapy of low dose atorvastatin and fenofibrate in mixed hyperlipidemia. Meth. Find. Exp. Clin. Pharmacol., 29: 217-222.
    CrossRef  |  Direct Link  |  
  29. Berry, V. and D.K. Badyal, 2006. Sensitivity of clinical isolates of Candida species to antifungal drugs. J. Med. Edu. Res 8: 214-216.
  30. Badyal, D.K., P.P. Khosla, R.S. Deswal and P.S. Matreja, 2006. Safety and efficacy of duloxetine versus venlafaxine in major depression in Indian patients. JK Sci., 8: 195-199.
  31. Badyal, D., 2006. Orphan diseases and drugs. Indian J. Pharmacol., 38: 299-300.
    Direct Link  |  
  32. Lata, H., D. Badyal and G.K. Ahuja, 2005. Apoptosis: Pathophysiological and pharmacological relevance. J. Anaesthesiol. Clin. Pharmacol., 21: 363-377.
  33. Kaur, J. and D.K. Badyal, 2005. Prescribing practices in a tertiary care hospital in Northern India. J. Pharmacivigilance Drug Safety, 2: 20-25.
  34. Berry, V., V. Saagr and D. Badyal, 2005. Acinetobacter meningitis. J. Acad. Clin. Microbiol., 2: 65-67.
  35. Badyal, D.K., J. Dhanoa, A.P. Dadhich, A.U. Athavale and S. Joshi et al., 2003. A multicentric study to evaluate efficacy and safety of cefetamet pivoxyl in lower respiratory tract infections in Indian patients. J. Indian Med. Assoc., 101: 436-438.
    Direct Link  |  
  36. Badyal, D.K., H. Lata and A.P. Dadhich, 2003. Animal models of hypertension and effect of drugs. Indian J. Pharmacol., 35: 349-362.
    Direct Link  |  
  37. Badyal, D.K. and A.P. Dadhich, 2001. Cytochrome P450 and drug interactions. Indian J. Pharmacol., 33: 248-259.
    Direct Link  |